LIGATURE THERAPEUTICS
Ligature Therapeutics is an early-stage biotechnology company that develops small molecule “protein degrader” therapeutics. Ligature Therapeutics is an early-stage drug discovery company that takes a novel approach towards developing small molecules for targeted protein degradation to treat intractable diseases. Ligature Therapeutics was founded by doctors Alvin Hung, Thomas Keller, and Congbao Kang with initial investment from Lightstone Singapore, a Singapore-focused venture fund founded in 2016 by Lightstone Ventures.
LIGATURE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2020-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Status:
Active
Total Funding:
6 M USD
Current Employees Featured
Founder
Investors List
Lightstone Ventures
Lightstone Ventures investment in Seed Round - Ligature Therapeutics
Seeds Capital
Seeds Capital investment in Seed Round - Ligature Therapeutics
More informations about "Ligature Therapeutics"
Ligature Therapeutics - Crunchbase Company Profile & Funding
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases. Search Crunchbase Start Free TrialSee details»
Ligature Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Ligature Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Ligature Therapeutics - Funding, Financials, Valuation & Investors
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.See details»
Spin-off to Develop Targeted Protein Degraders for …
Dec 21, 2020 · To develop potentially life-saving drugs, Ligature signed an exclusive licensing agreement with A*STAR’s commercialisation arm, A*ccelerate, for rights to the targeted protein degradation technology and …See details»
Ligature Therapeutics Launches, Raises USD $6M in Seed
Jan 5, 2021 · SINGAPORE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” …See details»
Ligature Therapeutics - Products, Competitors, Financials, …
Ligature Therapeutics is an early-stage biotech company developing small molecule “protein degrader” therapeutics. Ligature Therapeutics was founded in 2020 and is based in …See details»
Ligature Therapeutics - Updates, News, Events, Signals & Triggers
Ligature Therapeutics is focused on developing new inhibitors of MDM2, a protein associated with certain diseases. Their work includes synthesizing these agents, creating pharmaceutical …See details»
Ligature Therapeutics Launches, Raises USD $6M in Seed Financing
Jan 5, 2021 · SINGAPORE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” …See details»
Singapore based startup Ligature Therapeutics raises $6M in seed …
Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule ‘protein degrader’ therapeutics, has announced the close of $6 million in seed round funding.See details»
Ligature Therapeutics Launches, Raises USD $6M in Seed …
Jan 5, 2021 · SINGAPORE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” …See details»
The innovation network - A*STAR Research
Nov 16, 2022 · Several former A*STAR Graduate Academy (A*GA) scholars have founded spinoffs that have since gained traction with significant venture funding support. These include biotech startup Ligature Therapeutics, the first spinoff …See details»
Ligature Therapeutics - VentureRadar
Founded in 2020, Ligature Therapeutics Pte Ltd is an early-stage biotech company developing a novel approach to designing small molecules capable of... ... Find out more about Ligature …See details»
Ligature Therapeutics Launches, Raises USD $6M in Seed …
SINGAPORE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has …See details»
Singapore launches spin-off to develop treatment for intractable …
An early-stage drug discovery company, Ligature is founded by scientists from EDDC to advance research on treating intractable diseasesSee details»
Ligature Therapeutics - Contacts, Employees, Board Members
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.See details»
Singapore launches spin-off to develop treatment for intractable …
An early-stage drug discovery company, Ligature is founded by scientists from EDDC: Drs Alvin Hung, Thomas Keller and Congbao Kang, as well as life science-focused venture fund …See details»
Congbao Kang - A*STAR Research
Nov 16, 2023 · His team also conducts fragment screening and explores macromolecule-ligand interactions to drive forward drug discovery efforts. He co-founded Ligature Therapeutics to …See details»
Ligature Therapeutics Launches, Raises USD $6M in Seed Financing
The financing, led by Lightstone Ventures, with the participation of Enterprise Singapore’s investment arm, SEEDS Capital, will be used to build out the team and advance Ligature’s …See details»
Ligature Therapeutics Stock Price, Funding, Valuation, Revenue ...
See Ligature Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Ligature Therapeutics's post-money valuation and revenue.See details»
SG-based SolarHome to discontinue business, Ligature …
Mar 20, 2023 · Singapore-based solar energy startup SolarHome has filed to discontinue its business while early-stage biotech company Ligature Therapeutics has appointed a liquidator …See details»